Drawing based on the label description. No photo yet.
“ZEJULA 200-mg tablets are blue, debossed with "200" on one side and "Zejula" on the other side”
200 Zejula pill
Pill with imprint 200 Zejula is blue, oval, 16 mm and has been identified as Niraparib 200 mg. It is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms. It is supplied by Glaxosmithkline LLC.
Niraparib 200 mg
- Imprint
- 200 Zejula
- Strength
- 200 mg
- Used for
- Fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms
- Color
- Blue
- Shape
- Oval
- Size
- 16 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Glaxosmithkline LLC
- Drug class
- Poly(adp-ribose) polymerase inhibitor
- NDC
- 0173-0912, 0173-0912-13, 0173-0912-61
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Niraparib used for?
Niraparib is used for fallopian tube neoplasms, ovarian neoplasms and peritoneal neoplasms.
- Medicine type
- Poly(adp-ribose) polymerase inhibitor
Official uses from the US prescribing label
First-Line Maintenance Treatment of HRD-Positive Advanced Ovarian Cancer
ZEJULA is indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency (HRD)-positive status defined by either:
- a deleterious or suspected deleterious BRCA mutation, and/or
- genomic instability.
Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.
Maintenance Treatment of Recurrent Germline BRCA-Mutated Ovarian Cancer
ZEJULA is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAmut) recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
Select patients for therapy based on an FDA‑authorized companion diagnostic for ZEJULA.
From the FDA-approved label on DailyMed (published Aug 06, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows 200 and the other side shows Zejula.
- It is blue, oval, 16 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Zejula.
Ingredients
Active: Niraparib Tosylate
Inactive: Crospovidone, Unspecified, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Povidone, Unspecified, Silicon Dioxide, Water
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
LAC 200
Lacosamide 200 mg
Blue, oval, 17 mm
Used for focal seizures and tonic-clonic seizures
Schedule V
-
E 10
Levetiracetam 250 mg
Blue, oval, 15 mm
Used for focal seizures and tonic-clonic seizures
- RP 150 Maraviroc 150 mg Blue, oval, 15 mm Used for HIV
- zanu Zanubrutinib 160 mg Blue, oval, 16 mm Used for mantle-cell lymphoma
- 100M R Daraxonrasib 100 mg Blue, oval, 17 mm
- 654 Carbidopa and Levodopa 25 mg / 250 mg Blue, oval, 15 mm Used for Parkinson's disease
Other Niraparib pills
- 100 Zejula Niraparib 100 mg Gray, oval, 12 mm Used for fallopian tube neoplasms and ovarian neoplasms
- 300 Zejula Niraparib 300 mg Green, oval, 19 mm Used for fallopian tube neoplasms and ovarian neoplasms
- No picture yet DIN 02530031 Niraparib Tosylate 100 mg Zejula, Tablet, sold in Canada Used for fallopian tube neoplasms and ovarian neoplasms